Literature DB >> 17913268

Simultaneous subacute stent thrombosis of two sirolimus-eluting stents in a patient treated by ReoPro, thrombus aspiration and triple anti-platelet agents.

Jae-Youn Moon, Jong Won Chung, Ju Han Kim, Young Keun Ahn, Myung Ho Jeong.   

Abstract

Effective anti-platelet treatment has a key role in the prevention of stent thrombosis in the drug-eluting stent (DES) era. However, despite of the use of anti-platelet agents, stent thrombosis occurs in approximately 1% of patients, with an increased likelihood of occurrence in high-risk patients or complex lesion subset of patients [1-4]. According to the previous report, triple anti-platelet therapy (aspirin+clopidogrel+cilostazol) seemed to be more effective in preventing thrombotic complications after stenting than dual anti-platelet agent [5]. But, in this report, we present a patient with subacute stent thrombosis (ST) involving two different arteries simultaneously under the use of triple anti-platelet regimen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913268     DOI: 10.1016/j.ijcard.2007.07.046

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents.

Authors:  Yong-Hyun Kim; Soon Yong Suh; Seong Hwan Kim; Sang-Yup Lim; Seung-Young Roh; Ji-Bak Kim; Woo Hyuk Song; Jeong Cheon Ahn
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

2.  Short- and long-term outcomes of single bare metal stent versus drug eluting stent in nondiabetic patients with a simple de novo lesion in the middle and large vessel.

Authors:  Yue-jin Yang; Sheng Kang; Bo Xu; Ji-lin Chen; Shu-bin Qiao; Xue-wen Qin; Min Yao; Jue Chen; Yong-jian Wu; Hai-bo Liu; Jin-qing Yuan; Shi-jie You; Jian-jun Li; Jun Dai; Run-lin Gao
Journal:  J Transl Med       Date:  2008-08-06       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.